U.S. Professional Services Stock News

In recent months, Arista Networks has raised its full-year 2026 revenue outlook on the back of strong AI-driven networking demand and guided to approximately US$2.8 billion in second-quarter revenue, while also launching an AI-powered Edge Threat Management solution that unifies zero trust security and SD-WAN for branch offices. This combination of upgraded outlook, accelerating AI infrastructure adoption, and expansion into branch security reinforces Arista’s push to broaden its role across...

In July 2026, TTM Technologies presented its aerospace, defense, and advanced electronics capabilities at the Farnborough International Airshow in the United Kingdom, highlighting its mission systems, RF components, and complex PCB solutions for global customers. The event underscored TTM's growing role in supplying high-end electronics for AI data center infrastructure and mission-critical defense hardware, reinforcing its position in these specialized markets. We’ll now examine how TTM’s...

New U.S. tariffs on Canadian motor vehicles and related products are set to reshape costs across the auto supply chain, and that ripple effect is already on investors’ radar. While some companies may face higher input prices or trade friction, others could see fresh demand as buyers look for alternative suppliers or lean more on domestic aftermarket options. This article looks at 3 stocks from a U.S. Auto Parts and Aftermarket Suppliers screener that appear positively exposed to this news,...

Tariffs are moving again, and that can quickly change the risk and reward profile for U.S. manufacturers. With new charges on Brazilian and Canadian imports, ongoing levies on metals, autos, timber and semiconductors, and a fresh 100% tariff on many pharmaceuticals, investors are asking which domestic producers might stand to benefit. This article looks at stocks from a U.S. Domestic Manufacturing Stocks screener that are closely exposed to these tariff shifts, and will walk through 3...

Axsome Therapeutics reported that the FDA has accepted its New Drug Application for AXS-12 for the treatment of cataplexy in narcolepsy. The FDA does not plan to hold an advisory committee meeting as part of the review. The filing acceptance marks a key regulatory step for AXS-12, a potential option for a serious sleep disorder with unmet medical need. For Axsome Therapeutics (NasdaqGM:AXSM), this regulatory milestone arrives with the stock trading around $239.62 and a very large 3 year and...

United Rentals stock has delivered a strong 229.4% return over the past five years, yet its valuation checks are sending mixed messages, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples lean the other way. For investors trying to assess what the current US$1,035.06 share price really reflects, the split between these frameworks is central. Over five years United Rentals has returned 229.4%, which puts extra focus on whether recent...

With inflation, energy prices and interest rate expectations all pulling markets in different directions, many investors are looking for leaders whose interests are closely tied to long term outcomes rather than short term headlines. Founder led companies can fit that brief, as founders often have more of their own wealth, reputation and time invested in the business. This article looks at a curated Founder Led Companies screener that focuses on leaders who are personally committed to...

AbbVie stock has delivered a strong 156.7% total return over the past five years. However, there is a clear split in what the valuation tools indicate today. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while traditional market multiples make the shares look expensive, and the overall value score remains low. Over five years, AbbVie has returned 156.7%, which puts extra focus on whether current buyers are paying too much for that track record. Progress...

Merck (NYSE:MRK) is seeing new clinical progress for its KEYTRUDA franchise in Europe and in hard to treat cancers. Agilent received EU approval to use its PD-L1 IHC 22C3 pharmDx test as a companion diagnostic to identify patients eligible for KEYTRUDA in additional gynecologic cancers. Phanes Therapeutics expanded its clinical trial collaboration with Merck to study KEYTRUDA in combination regimens for biliary tract cancer. These updates highlight how Merck is continuing to develop...

HP (HPQ) is back in focus after Goodwall expanded their partnership to bring HP devices and AI skills programs to young people across Brazil and Latin America, tying education access to future customer relationships. See our latest analysis for HP. HP’s recent partnership news sits alongside firm share price momentum, with a 90 day share price return of 24.63% and year to date share price return of 13.47%, while the 5 year total shareholder return of 6.11% and 3 year total shareholder return...

Knight-Swift Transportation Holdings Inc. recently reported past second-quarter 2026 results, with sales of US$1,764.39 million, revenue of US$2,095.71 million, and net income of US$43.19 million, all higher than a year earlier, and earnings per share from continuing operations improving on both a basic and diluted basis. Beyond beating Wall Street expectations, the company highlighted sharper truckload market tightening, better pricing, and improved network efficiency, which together...

Affirm Holdings (AFRM) is back in focus after Bernstein initiated coverage with an Outperform rating, spotlighting the buy now pay later provider’s position across 27 million users and 515,000 merchants worldwide. See our latest analysis for Affirm Holdings. Affirm Holdings’ share price has cooled recently, with a 1-day share price return showing a 1.08% decline and a 7-day share price return showing a 9.54% decline, yet the 90-day share price return of 17.36% and 1-year total shareholder...

Recent data published in Parasites & Vectors showed that Elanco Animal Health’s Credelio QuattroTM kills black-legged and lone star ticks faster and more consistently over 28 days than rival products Simparica Trio and NexGard Plus, while also carrying a U.S. FDA-approved claim for preventing Lyme disease in dogs via rapid tick kill. The studies highlight that Credelio Quattro uniquely maintains an 8-hour speed of kill for black-legged ticks through Day 28, which directly targets the early...

Pinnacle Financial Partners (PNFP) is back in focus after reporting second quarter 2026 earnings, with net income of US$328 million and basic earnings per share from continuing operations of US$2.07. See our latest analysis for Pinnacle Financial Partners. The latest earnings beat has arrived against a mixed backdrop for Pinnacle Financial Partners, with the share price at US$97.36, a modest 1 day share price return of 0.59% and a year to date share price return of 2.38%. The 1 year total...

Houlihan Lokey stock has delivered a 76.5% total return over the past five years, yet its current valuation picture is split, with the Excess Returns intrinsic value estimate pointing to upside while earnings based multiples suggest the shares trade at a richer level. Over five years, a 76.5% return suggests Houlihan Lokey has rewarded patient shareholders, even though the share price has recently been under pressure. For a specialist advisory firm like Houlihan Lokey, expectations for...

Church & Dwight (CHD) is back in focus as investors look ahead to its late July second quarter earnings release, following a series of upside surprises and ongoing margin focused productivity efforts. See our latest analysis for Church & Dwight. At a share price of $97.13, Church & Dwight has a 1-month share price return of 3.62% and a year to date share price return of 17.53%. Its 1-year total shareholder return of 1.38% suggests recent momentum has been stronger in the short term than over...

Earlier in July 2026, Kontoor Brands’ Lee label introduced the LQD Denim collection in the US and Europe, while Wrangler unveiled Toughlite, a lighter-weight, airflow-focused take on its Cowboy Cut jeans, both positioned as premium yet versatile denim offerings with prices around $70–$130. These product launches highlight Kontoor’s emphasis on fabric innovation and comfort-led design to broaden where and how its core denim brands can be worn, from work to more polished social settings. We’ll...

Enovix Corporation announced that Dr. Michael Vyvoda, a former Apple Product Operations Director who helped scale AirPods manufacturing, joined as Chief Operating Officer on July 29, 2026, taking charge of global manufacturing, supply chain and operations engineering across Malaysia, Korea and India. By consolidating key operations leaders under a single COO with deep high-volume manufacturing experience, Enovix is signaling a reinforced focus on execution as it expands global...

Hycroft Mining Holding (HYMC) has moved to expand its operational leadership by appointing Michael Deal as Senior Vice President and Chief Operating Officer, effective August 24, 2026, following a long career in North American gold and silver mining. See our latest analysis for Hycroft Mining Holding. The appointment of Michael Deal comes at a time when Hycroft Mining Holding’s share price has been volatile, with a 1-day share price return of 4.73% and a 30-day share price return that...

Reports that Reddit (RDDT) may restrict Google’s access to its content for AI training have pushed the company’s US$60 million a year licensing deal into focus for investors. See our latest analysis for Reddit. The share price reaction to the Google licensing headlines has been sharp, with Reddit’s 1 day share price return down 8.32% and 7 day share price return down 13.96%. At the same time, the 90 day share price return of 11.39% and 1 year total shareholder return of 16.62% point to...

Camtek (CAMT) has drawn attention after recent trading produced mixed short term moves, with the stock up about 0.4% in the latest session but down roughly 7% over the past month. See our latest analysis for Camtek. Zooming out, Camtek’s share price has the latest close at $156.79, with recent weakness over the past three months contrasting with a much stronger year to date share price return and very large five year total shareholder return. This suggests long term momentum, while near term...

Nu Holdings has delivered an 84.8% return over the past three years, yet its valuation signals are split, with an Excess Returns intrinsic value estimate suggesting about 11.1% upside while market multiples lean toward the stock looking expensive. Nu Holdings' 84.8% return over three years puts recent shareholders in a strong position. This raises the question of how much upside is left from here. Recent progress on full banking licenses in Brazil and Mexico can support expectations for...

RH stock has had a difficult run over the past few years, and the latest valuation work points to shares trading at a premium, with both a Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples indicating the stock screens as overvalued rather than as a clear bargain. RH has declined about 74.0% over the past five years, which means long term shareholders are still sitting on sizeable losses despite shorter term rebounds. Expectations for stronger earnings growth...

Vistra stock has delivered an extremely strong 5 year return, but after that run the valuation screens now point to something closer to a middle ground than a clear bargain or clear excess. Over the last 5 years, Vistra has returned about 8.4x an initial investment, which puts extra focus on whether the current price still reflects its fundamentals. Growing attention on power demand from data centers and AI infrastructure can support long term earnings expectations for Vistra, while...